GLPwatch
Once-weekly glucagon-like peptide 1 receptor agonists.
J Pak Med Assoc · 2015
Last updated 2026-05-28Once-weekly glucagon-like peptide 1 receptor agonists (QW GLP1RA) are a new class of drugs for diabetes treatment. This review explains their basic and clinical pharmacology, as well as how they are used and dosed in treatment.
AI summary of the abstract below.
| Journal | J Pak Med Assoc, 2015 |
|---|---|
| Citations | 1 |
| Relative citation ratio | 0.02 |
| NIH percentile | 4 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Obesity, Cardiovascular Risk Reduction, Chronic Kidney Disease |
Abstract
The once-weekly glucagon-like peptide 1 receptor agonists (QW GLP1RA) represent a major advancement in diabetes pharmaco-therapeutics. This review describes the basic, clinical, and comparative pharmacology of this novel class of drugs. It highlights the clinical placement and posology of these drugs.
Verbatim abstract via PubMed 26160096 ↗